OBJECTIVE: We investigated the distribution of serious comorbidity in patients with newly diagnosed oesophageal and gastric cancer between 1993 and 2001. Our special interest was comparing distal oesophageal and gastric cardia adenocarcinoma patients since a common origin of these tumours has been suggested. METHODS: Data on comorbidity (previous cancers, chronic obstructive pulmonary diseases, cardiovascular and cerebrovascular diseases, hypertension, ulcerative digestive tract diseases, liver diseases and diabetes) were derived from a population-based database in The Netherlands to compare risk factor profiles for 479 oesophageal squamous cell carcinomas, 339 distal oesophageal adenocarcinomas, 570 cardia adenocarcinomas and 1965 subcardia cancers. RESULTS: A comparable age and gender distribution was shown in distal oesophageal and cardia adenocarcinoma patients. After adjustment for age and gender, only the prevalence of previous cancers differed between adenocarcinomas of distal oesophagus and cardia [more frequent in distal oesophageal adenocarcinoma patients, odds ratio (OR) = 1.84, P = 0.01]. Ulcerative and liver diseases were more prevalent in oesophageal squamous cell carcinoma patients as compared with distal oesophageal adenocarcinoma patients (OR = 1.90, P = 0.02 and OR = 8.82, P = 0.04, respectively), whereas diabetes was more prevalent in the latter (OR = 0.56, P = 0.03). Cardia adenocarcinoma patients significantly more often had hypertension as compared with subcardia cancer patients (OR = 1.53, P = 0.001), whereas the latter more often suffered from previous cancers and ulcerative diseases (OR = 0.54, P = 0.0009 and OR = 0.25, P < 0.0001, respectively). CONCLUSIONS: In terms of comorbidity at diagnosis, cardia adenocarcinoma patients resemble distal oesophageal adenocarcinoma patients rather than gastric subcardia carcinoma patients, with likewise equal age and gender distribution.
OBJECTIVE: We investigated the distribution of serious comorbidity in patients with newly diagnosed oesophageal and gastric cancer between 1993 and 2001. Our special interest was comparing distal oesophageal and gastric cardia adenocarcinomapatients since a common origin of these tumours has been suggested. METHODS: Data on comorbidity (previous cancers, chronic obstructive pulmonary diseases, cardiovascular and cerebrovascular diseases, hypertension, ulcerative digestive tract diseases, liver diseases and diabetes) were derived from a population-based database in The Netherlands to compare risk factor profiles for 479 oesophageal squamous cell carcinomas, 339 distal oesophageal adenocarcinomas, 570 cardia adenocarcinomas and 1965 subcardia cancers. RESULTS: A comparable age and gender distribution was shown in distal oesophageal and cardia adenocarcinomapatients. After adjustment for age and gender, only the prevalence of previous cancers differed between adenocarcinomas of distal oesophagus and cardia [more frequent in distal oesophageal adenocarcinomapatients, odds ratio (OR) = 1.84, P = 0.01]. Ulcerative and liver diseases were more prevalent in oesophageal squamous cell carcinomapatients as compared with distal oesophageal adenocarcinomapatients (OR = 1.90, P = 0.02 and OR = 8.82, P = 0.04, respectively), whereas diabetes was more prevalent in the latter (OR = 0.56, P = 0.03). Cardia adenocarcinomapatients significantly more often had hypertension as compared with subcardia cancerpatients (OR = 1.53, P = 0.001), whereas the latter more often suffered from previous cancers and ulcerative diseases (OR = 0.54, P = 0.0009 and OR = 0.25, P < 0.0001, respectively). CONCLUSIONS: In terms of comorbidity at diagnosis, cardia adenocarcinomapatients resemble distal oesophageal adenocarcinomapatients rather than gastric subcardia carcinomapatients, with likewise equal age and gender distribution.
Authors: Michael B Cook; Katherine A McGlynn; Susan S Devesa; Neal D Freedman; William F Anderson Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-07-12 Impact factor: 4.254
Authors: Benjamin S Glicksberg; Li Li; Wei-Yi Cheng; Khader Shameer; Jörg Hakenberg; Rafael Castellanos; Meng Ma; Lisong Shi; Hardik Shah; Joel T Dudley; Rong Chen Journal: Pac Symp Biocomput Date: 2015
Authors: A Carmona-Bayonas; P Jiménez-Fonseca; A Custodio; M Sánchez Cánovas; R Hernández; C Pericay; I Echavarria; A Lacalle; L Visa; A Rodríguez Palomo; M Mangas; J M Cano; E Buxo; F Álvarez-Manceñido; T García; J E Lorenzo; M Ferrer-Cardona; A Viudez; A Azkarate; A Ramchandani; D Arias; F Longo; C López; R Sánchez Bayona; M L Limón; A Díaz-Serrano; A Fernández Montes; P Sala; P Cerdá; F Rivera; J Gallego Journal: Gastric Cancer Date: 2017-04-09 Impact factor: 7.370
Authors: Jae Moon Yoon; Ki Young Son; Chun Sick Eom; Daniel Durrance; Sang Min Park Journal: World J Gastroenterol Date: 2013-02-14 Impact factor: 5.742
Authors: W J Louwman; M J Aarts; S Houterman; F J van Lenthe; J W W Coebergh; M L G Janssen-Heijnen Journal: Br J Cancer Date: 2010-10-26 Impact factor: 7.640
Authors: Monique M E M Bos; Ilona W M Verburg; Ineke Dumaij; Jacqueline Stouthard; Johannes W R Nortier; Dick Richel; Eric P A van der Zwan; Nicolette F de Keizer; Evert de Jonge Journal: Cancer Med Date: 2015-04-18 Impact factor: 4.452
Authors: Nikolaj S Baranov; Frans van Workum; Jolijn van der Maas; Ewout Kouwenhoven; Marc van Det; Frits J H van den Wildenberg; Fatih Polat; Grard A P Nieuwenhuijzen; Misha D P Luyer; Camiel Rosman Journal: J Gastrointest Surg Date: 2018-12-18 Impact factor: 3.452
Authors: Georgios Lyratzopoulos; Josephine M Barbiere; Chetna Gajperia; Michael Rhodes; David C Greenberg; Karen A Wright Journal: BMC Health Serv Res Date: 2009-12-15 Impact factor: 2.655